Organizing human specimen collections: Getting the best out of biobanks

The diversity of biobanks, collections of human specimens from a variety of sources, raises questions about the best way to manage and govern them, finds a study published in BioMed Central's open access journal Genome Medicine. The research highlights difficulties in standardizing these collections and how to make these samples available for research.

Biobanks have been around for decades, storing hundreds of millions of human specimens. But there has been a dramatic increase in the number of biobanks in the last ten years, since the human genome sequencing project. Because there is no central registry of biobanks in the US, researchers from the University of North Carolina at Chapel Hill invited over 600 biobanks to participate in an .

The study finds great diversity in when and why these biobanks were created, how they are organized, who pays for them, and what specimens they store. Over half were set up to facilitate research into a particular disease, mainly cancer, but others were created as a 'home' for older sample collections. The number of samples within each is hugely variable, from tens to millions, and can include clinical, pediatric or post-mortem samples, or from research, with origins as varied as blood and solid tissues, or hair and toe nails.

Talking about attempts to put into place policies to regulate biobanks, Prof Gail Henderson, who led this project explained, "Biobanks are part of an emerging and rapidly evolving industry, with an increasingly central role in . Because they have developed in different contexts with different goals and funding sources, any attempt to control or standardize biobanks will need to take into account their organizational diversity and their individual practices and challenges. It is unlikely that a one-size policy will fit all."

More information: Characterizing biobank organizations in the U.S.: results from a national survey Gail E Henderson, R Jean Cadigan, Teresa P Edwards, Ian Conlon, Anders G Nelson, James P Evans, Arlene M Davis, Catherine Zimmer and Bryan J Weiner Genome Medicine, (in press)

add to favorites email to friend print save as pdf

Related Stories

Europe tackles ethics of biobanks

Jun 20, 2012

Collections of human biological samples used in medical research should be governed by clear rules that safeguard ethics while advancing knowledge, scientists said Wednesday at a Council of Europe symposium.

Public prefers limited informed consent process for biobanks

Jun 29, 2011

Biobanks are repositories for tissue samples, usually in the form of blood or saliva or leftover tissue from surgical procedures. These samples are collected and used for future research, including genetic research. They ...

Keeping DNA 'all in the family'

Oct 06, 2009

Scientists look for clues about therapies and cures for life-threatening childhood illnesses in children's DNA -- it seems only logical to do so. But the decision as to who should have access to DNA samples from children ...

Recommended for you

Changes in scores of genes contribute to autism risk

Oct 29, 2014

Small differences in as many as a thousand genes contribute to risk for autism, according to a study led by Mount Sinai researchers and the Autism Sequencing Consortium (ASC), and published today in the journal Nature.

Dozens of genes associated with autism in new research

Oct 29, 2014

Two major genetic studies of autism, led in part by UC San Francisco scientists and involving more than 50 laboratories worldwide, have newly implicated dozens of genes in the disorder. The research shows ...

Genetic link to kidney stones identified

Oct 29, 2014

A new breakthrough could help kidney stone sufferers get an exact diagnosis and specific treatment after genetic links to the condition were identified.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.